Seino, Y., Min, K. W., Niemoeller, E., & Takami, A. (2012). Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)*. Blackwell Publishing Ltd.
Čikaški stil citiranjaSeino, Y., K W. Min, E. Niemoeller, i A. Takami. Randomized, Double-blind, Placebo-controlled Trial of the Once-daily GLP-1 Receptor Agonist Lixisenatide in Asian Patients With Type 2 Diabetes Insufficiently Controlled On Basal Insulin With or Without a Sulfonylurea (GetGoal-L-Asia)*. Blackwell Publishing Ltd, 2012.
MLA način citiranjaSeino, Y., K W. Min, E. Niemoeller, i A. Takami. Randomized, Double-blind, Placebo-controlled Trial of the Once-daily GLP-1 Receptor Agonist Lixisenatide in Asian Patients With Type 2 Diabetes Insufficiently Controlled On Basal Insulin With or Without a Sulfonylurea (GetGoal-L-Asia)*. Blackwell Publishing Ltd, 2012.